Back to News
Market Impact: 0.35
ANI Pharmaceuticals (ANIP) Surpasses Q3 Earnings and Revenue Estimates
Source: zacks.com
Corporate EarningsCompany FundamentalsAnalyst Estimates
ANI Pharmaceuticals reported quarterly earnings of $2.70 per share, beating the Zacks consensus estimate of $2.17 by $0.53, or about 24%. Earnings were up from $2.04 per share in the year-ago quarter.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment
ANIP0.65
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- Qualcomm slides 9% after earnings, leading post-election chip stock sell-off
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request
- Tapestry CEO on Earnings Beat, Consumer Outlook